To determine whether the p38 mediated stress signaling might associate with the ERα status in clinical samples of breast cancer, we analyzed 42 invasive breast cancer samples for phospho-p38 and ERα expression by immunohistochemistry (Fig. 7f; Supplementary Figure 6f & 7a, b). This evidence concerns the gene MAPK14 and breast cancer.